Search

Search Results

• RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES

  Julie Schanz, Friederike Braulke, Detlef Haase

  e2015034

  2015-04-23

  https://doi.org/10.4084/mjhid.2015.034

  3675

  PDF: 1618

  HTML: 11510

  Figures Haase: 180

• OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT

  Ulrike Bacher, Stefanie von Matt, Yara Banz, Behrouz Mansouri, Urban Novak, Thomas Pabst

  e2023025

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.025

  1247

  HTML: 286

  PDF: 907

  Suppl. Files: 434

• REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy

  Ulrike Bacher, Simon Brechbühl, Barbara Jeker, Thomas Pabst

  e2021012

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.012

  1506

  PDF: 569

  HTML: 171

• Experiences with next-generation sequencing in relapsed acute myeloid leukemia: a patient case series

  Dr. Johanna Flach, Dr. Evgenii Shumilov, Dr. Naomi Porret, Inna Shakhanova, Myriam Legros, Dr. Marie-Noëlle Kronig, Dr. Raphael Joncourt, Prof. Ulrike Bacher, Prof. Thomas Pabst

  e2020068

  2020-08-29

  https://doi.org/10.4084/mjhid.2020.068

  935

  PDF: 764

  HTML: 252